167 related articles for article (PubMed ID: 19285155)
1. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Tervaert JW
Autoimmun Rev; 2009 Sep; 9(1):53-7. PubMed ID: 19285155
[TBL] [Abstract][Full Text] [Related]
2. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
[TBL] [Abstract][Full Text] [Related]
3. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
Freire de Carvalho J; Sherer Y; Shoenfeld Y
Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
[TBL] [Abstract][Full Text] [Related]
4. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
6. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
7. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
[TBL] [Abstract][Full Text] [Related]
8. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
9. OxLDL-IgG immune complexes induce survival of human monocytes.
Oksjoki R; Kovanen PT; Lindstedt KA; Jansson B; Pentikäinen MO
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):576-83. PubMed ID: 16373614
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylcholine-targeting immunization reduces atherosclerosis.
Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
[TBL] [Abstract][Full Text] [Related]
12. Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion.
Nagarajan S
Immunol Lett; 2007 Jan; 108(1):52-61. PubMed ID: 17081622
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin and atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):311-9. PubMed ID: 16391407
[TBL] [Abstract][Full Text] [Related]
14. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.
Kyaw T; Tay C; Khan A; Dumouchel V; Cao A; To K; Kehry M; Dunn R; Agrotis A; Tipping P; Bobik A; Toh BH
J Immunol; 2010 Oct; 185(7):4410-9. PubMed ID: 20817865
[TBL] [Abstract][Full Text] [Related]
15. Oxidation-specific epitopes are important targets of innate immunity.
Chou MY; Hartvigsen K; Hansen LF; Fogelstrand L; Shaw PX; Boullier A; Binder CJ; Witztum JL
J Intern Med; 2008 May; 263(5):479-88. PubMed ID: 18410591
[TBL] [Abstract][Full Text] [Related]
16. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
van Es T; van Puijvelde GH; Ramos OH; Segers FM; Joosten LA; van den Berg WB; Michon IM; de Vos P; van Berkel TJ; Kuiper J
Biochem Biophys Res Commun; 2009 Oct; 388(2):261-5. PubMed ID: 19660432
[TBL] [Abstract][Full Text] [Related]
17. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human monoclonal autoantibody Fab fragments against oxidized LDL.
Jeon YE; Seo CW; Yu ES; Lee CJ; Park SG; Jang YJ
Mol Immunol; 2007 Feb; 44(5):827-36. PubMed ID: 16793138
[TBL] [Abstract][Full Text] [Related]
20. Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
Gonçalves I; Cherfan P; Söderberg I; Nordin Fredrikson G; Jonasson L
Autoimmunity; 2009 Mar; 42(3):203-8. PubMed ID: 19301201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
